Literature DB >> 12777313

Role for chymase in heart failure: angiotensin II-dependent or -independent mechanisms?

Jorma O Kokkonen, Ken A Lindstedt, Petri T Kovanen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12777313     DOI： 10.1161/01.CIR.0000074786.92067.AA

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  14 in total

Review 1.  Angiotensin-(1-12): a chymase-mediated cellular angiotensin II substrate.

Authors:  Sarfaraz Ahmad; Jasmina Varagic; Leanne Groban; Louis J Dell'Italia; Sayaka Nagata; Neal D Kon; Carlos M Ferrario
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

Review 2.  Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system.

Authors:  Alicia C Reid; Jacqueline A Brazin; Christopher Morrey; Randi B Silver; Roberto Levi
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

3.  Characterization of mast cell populations using different methods for their identification.

Authors:  Dmitri Atiakshin; Vera Samoilova; Igor Buchwalow; Werner Boecker; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2017-02-27       Impact factor: 4.304

Review 4.  The role and regulation of cardiac angiotensin-converting enzyme for noninvasive molecular imaging in heart failure.

Authors:  Omer Aras; Steven A Messina; Jamshid Shirani; William C Eckelman; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2007-04       Impact factor: 2.931

5.  Sex differences in gene expression in response to ischemia in the human left ventricular myocardium.

Authors:  Gregory Stone; Ashley Choi; Oliva Meritxell; Joshua Gorham; Mahyar Heydarpour; Christine E Seidman; Jon G Seidman; Sary F Aranki; Simon C Body; Vincent J Carey; Benjamin A Raby; Barbara E Stranger; Jochen D Muehlschlegel
Journal:  Hum Mol Genet       Date:  2019-05-15       Impact factor: 6.150

6.  Chymase mediates angiotensin-(1-12) metabolism in normal human hearts.

Authors:  Sarfaraz Ahmad; Chih-Chang Wei; Jose Tallaj; Louis J Dell'Italia; Norihito Moniwa; Jasmina Varagic; Carlos M Ferrario
Journal:  J Am Soc Hypertens       Date:  2013-01-10

Review 7.  Inhibition of RAAS--when is it too much?

Authors:  Pablo Navarro; Robert Moskowitz; Thierry H Le Jemtel
Journal:  Curr Heart Fail Rep       Date:  2004-07

8.  Combination of Chymostatin and Aliskiren attenuates ER stress induced by lipid overload in kidney tubular cells.

Authors:  Miaojuan Qiu; Suchun Li; Lizi Jin; Pinning Feng; Yonglun Kong; Xiaoduo Zhao; Yu Lin; Yunyun Xu; Chunling Li; Weidong Wang
Journal:  Lipids Health Dis       Date:  2018-07-31       Impact factor: 3.876

9.  Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation.

Authors:  Johannes J Kovarik; Christopher C Kaltenecker; Chantal Kopecky; Oliver Domenig; Marlies Antlanger; Johannes Werzowa; Farsad Eskandary; Renate Kain; Marko Poglitsch; Sabine Schmaldienst; Georg A Böhmig; Marcus D Säemann
Journal:  Sci Rep       Date:  2019-07-05       Impact factor: 4.379

10.  Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.

Authors:  Javier Barallobre-Barreiro; Rahmi Oklu; Marc Lynch; Marika Fava; Ferheen Baig; Xiaoke Yin; Temo Barwari; David N Potier; Hassan Albadawi; Marjan Jahangiri; Karen E Porter; Michael T Watkins; Sanjay Misra; Julianne Stoughton; Manuel Mayr
Journal:  Cardiovasc Res       Date:  2016-04-11       Impact factor: 10.787
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.